The company intends to use the funds for (1) new product introductions and enhanced 3D printed personalized surgical solutions in upper/lower extremity, spine, and trauma, (2) ongoing development of machine learning enabled software for surgical planning and implant design, (3) fundamental research, preclinical, and clinical studies, and (4) expansion of the commercial team to support market traction.
Led by Ken Gall Ph.D., co-founder, Restor3d is a medical device company focused on enabling surgeons to improve the reconstruction and repair of the human body through 3D printed implants with enhanced anatomical fit and superior integrative properties. The company seeks to improve medical device solutions by leveraging expertise in 3D printing of advanced biomedical materials, anatomic and kinematic modeling, and AI based planning and design tools.In 2021, restor3d announced it had merged with Kinos Medical, a total ankle replacement company, which helped accelerate its expansion into the high-growth extremity arthroplasty markets in the U.S. restor3d has multiple FDA product clearances that span lower extremity, upper extremity, spine, and trauma.In early 2023, restor3d will move into a new facility in Research Triangle Park that will expand capabilities for patient specific digital design, in-house manufacturing of implants and instruments, as well as surgeon training and education labs.
05/04/2022
